Cite
HARVARD Citation
Shi, Y. et al. (2022). Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China. Thoracic cancer. 13 (3), pp. 412-422. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shi, Y. et al. (2022). Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China. Thoracic cancer. 13 (3), pp. 412-422. [Online].